 |
 Video: What is a Stock Split?
|
|
|
| Amphastar Pharmaceuticals is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient (API) products. Co.'s reportable segments are: finished pharmaceutical products, which manufactures, markets and distributes Primatene Mist®, glucagon, enoxaparin, naloxone, phytonadione, lidocaine, epinephrine, various critical and non-critical care drugs; and API, which manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development. According to our Amphastar Pharmaceuticals stock split history records, Amphastar Pharmaceuticals has had 0 splits. | |
|
Amphastar Pharmaceuticals (AMPH) has 0 splits in our Amphastar Pharmaceuticals stock split history database.
Looking at the Amphastar Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Amphastar Pharmaceuticals shares, starting with a $10,000 purchase of AMPH, presented on a split-history-adjusted basis factoring in the complete Amphastar Pharmaceuticals stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/26/2014 |
|
| End date: |
04/25/2024 |
|
| Start price/share: |
$10.01 |
|
| End price/share: |
$40.83 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
307.89% |
|
| Average Annual Total Return: |
15.36% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$40,786.99 |
|
| Years: |
9.84 |
|
|
|
|
|
